Bronchiolitis.
Lancet
; 400(10349): 392-406, 2022 07 30.
Article
in English
| MEDLINE | ID: covidwho-1972375
ABSTRACT
Viral bronchiolitis is the most common cause of admission to hospital for infants in high-income countries. Respiratory syncytial virus accounts for 60-80% of bronchiolitis presentations. Bronchiolitis is diagnosed clinically without the need for viral testing. Management recommendations, based predominantly on high-quality evidence, advise clinicians to support hydration and oxygenation only. Evidence suggests no benefit with use of glucocorticoids or bronchodilators, with further evidence required to support use of hypertonic saline in bronchiolitis. Evidence is scarce in the intensive care unit. Evidence suggests use of high-flow therapy in bronchiolitis is limited to rescue therapy after failure of standard subnasal oxygen only in infants who are hypoxic and does not decrease rates of intensive care unit admission or intubation. Despite systematic reviews and international clinical practice guidelines promoting supportive rather than interventional therapy, universal de-implementation of interventional care in bronchiolitis has not occurred and remains a major challenge.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Bronchiolitis
/
Bronchiolitis, Viral
Type of study:
Diagnostic study
/
Prognostic study
/
Reviews
/
Systematic review/Meta Analysis
Limits:
Humans
/
Infant
Language:
English
Journal:
Lancet
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS